3,5-Bis(ethoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-4-carboxylic acid
暂无分享,去创建一个
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] J. Schwartz,et al. Organometallics , 1987, Science.
[3] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[4] De novo synthesis of substituted pyridines , 2004 .
[5] R. Tacke,et al. Synthesis and Pharmacological Properties of Silicon-Containing 1,4-Dihydropyridine Derivatives: Calcium Channel Antagonists and α1 Adrenoceptor Antagonists of the Sila-niguldipine Type , 2004 .
[6] A M Triggle,et al. Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine. , 1980, Journal of medicinal chemistry.
[7] C. Romming,et al. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine. , 1982, Journal of medicinal chemistry.
[8] A. Fleckenstein. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.